SCUELJapan healthcare data

Home › Therapeutic areas › Other diagnostic agents (excluding in vitro diagnostics)

Japan market screening · Therapeutic class

Other diagnostic agents (excluding in vitro diagnostics) in Japan

その他の診断用薬(体外診断用医薬品を除く。) · Japan Standard Commodity Classification

15 molecules in this class are marketed in Japan across 44 products. 2 of those products are not shipping normally today — 4.5% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.

15Molecules
44Marketed products
2Products constrained

Molecules in this class

Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.

MoleculeProducts CompaniesConstrained Supply mix
Meglumine Gadoterateガドテル酸メグルミン102—
Gadoteridolガドテリドール82—
Gadobutrolガドブトロール411
Gadoquatrane Hydrateガドクアトラン水和物41—
Aminolevulinic Acid Hydrochlorideアミノレブリン酸塩酸塩31—
Fluoresceinフルオレセイン22—
Gadoxetate Sodiumガドキセト酸ナトリウム21—
Indocyanine Greenインドシアニングリーン22—
Methacholine Chlorideメタコリン塩化物22—
Urea (13C)尿素(13C)22—
Ferric Ammonium Citrateクエン酸鉄アンモニウム11—
Ferucarbotranフェルカルボトラン111
Gallium (68Ga) Gozetotideガリウム(68Ga)ゴゼトチド11—
Perflubutaneペルフルブタン11—
Phentolamine Mesilateフェントラミンメシル酸塩11—
Normal supply Limited supply Supply suspended

How to read this

Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.

Screening this area in Japan?

Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.

Send an enquiry

Our Database Division replies in English within three business days (Japan time).